| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
- Pheniramine
-
- $1.00
-
2026-02-02
- CAS:86-21-5
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 50tons
- Pheniramine
-
- $7.00
-
2019-09-02
- CAS: 86-21-5
- Min. Order: 1KG
- Purity: 99%
|
| | Pheniramine Basic information |
| Product Name: | Pheniramine | | Synonyms: | n,n-dimethyl-3-phenyl-3-(2-pyridyl)propylamine;PHENIRAMINE;2-(alpha-(2-(dimethylamino)ethyl)benzyl)-pyridin;2-[(S)-α-[2-(Dimethylamino)ethyl]benzyl]pyridine;2-[α-(2-Dimethylaminoethyl)benzyl]pyridine;Pheniramine solution;N,N-dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine;Dexchlorpheniramine EP Impurity A | | CAS: | 86-21-5 | | MF: | C16H20N2 | | MW: | 240.34 | | EINECS: | 201-656-2 | | Product Categories: | | | Mol File: | 86-21-5.mol |  |
| | Pheniramine Chemical Properties |
| Melting point | <25 °C | | Boiling point | bp13 181°; bp2 142°; bp0.5 135° | | density | 1.0081 | | refractive index | nD25 1.5519 to 1.5521 | | Fp | 9℃ | | storage temp. | -20°C | | solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | | form | Oil | | pka | pKa 4.03± 0.08;9.32± 0.06(H2O,t undefined,I=0.30(NaCl)) (Uncertain) | | color | Colourless | | Major Application | clinical testing | | InChI | 1S/C16H20N2/c1-18(2)13-11-15(14-8-4-3-5-9-14)16-10-6-7-12-17-16/h3-10,12,15H,11,13H2,1-2H3 | | InChIKey | IJHNSHDBIRRJRN-UHFFFAOYSA-N | | SMILES | CN(C)CCC(c1ccccc1)c2ccccn2 | | CAS DataBase Reference | 86-21-5(CAS DataBase Reference) | | NIST Chemistry Reference | Pyridine, 2[alpha-(2-dimethyl aminoethyl)benzyl](86-21-5) |
| Hazard Codes | F,T | | Risk Statements | 11-23/24/25-39/23/24/25 | | Safety Statements | 16-36/37-45 | | RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution | | WGK Germany | 1 | | Storage Class | 3 - Flammable liquids | | Hazard Classifications | Acute Tox. 3 Dermal
Acute Tox. 3 Inhalation
Acute Tox. 3 Oral
Flam. Liq. 2
STOT SE 1 |
| | Pheniramine Usage And Synthesis |
| Originator | Trimeton Maleate, Schering ,US,1948 | | Uses | Pheniramine is an antigripal drug. Also, it is derived from 2-Benzylpyridine (B288740), which is a benzylpyridine with antifungal properties. 2-Benzylpyridine is also used as a chromogenic reagent for micro determination of Molybednum. | | Definition | ChEBI: N,N-dimethyl-3-phenyl-3-(2-pyridinyl)-1-propanamine is a tertiary amino compound and a member of pyridines. | | Manufacturing Process | According to US Patent 2,676,964: to 1.0 mol of potassium amide in 3 liters of liquid ammonia, is added 1.0 mol of 2-benzylpyridine. After 15 minutes, 1.1 mols of β-dimethylaminoethyl chloride are added. The ammonia is allowed to evaporate and the reaction product decomposed with water and ether extracted. The ether layer is dried over sodium sulfate and after evaporation the residue is distilled, giving the 3-phenyl-3-(2-pyridyl)-N,Ndimethylpropylamine, BP 139°-142°C/1-2 mm. The maleate is produced by reaction with maleic acid. | | Therapeutic Function | Antihistaminic | | Synthesis Reference(s) | The Journal of Organic Chemistry, 59, p. 7125, 1994 DOI: 10.1021/jo00102a044 | | Safety Profile | Poison by intravenous
route. Human systemic effects by ingestion:
central nervous system effects. When heated
to decomposition it emits toxic fumes of
NOx. | | Enzyme inhibitor | This antihistamine (FWfree-base = 240.35 g/mol; CAS 86-21-5; insoluble in water; maleate and p-aminosalicylate salts are water-soluble), also known as N,N-dimethyl-g-phenyl-2-pyridinepropanamide, is more frequently abused than other antihistamines relative to its market share. One of the histamine H1 antagonists with little sedative action, pheniramine is often used in treatment of hay fever, rhinitis, allergic dermatoses, and pruritus. Target(s): H1 histamine receptor; and histamine Nmethyltransferase, mildly inhibited. |
| | Pheniramine Preparation Products And Raw materials |
|